Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 50.50
+2.50 (5.21%)
At close: Feb 11, 2026
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.41 billion as of February 11, 2026. Its market cap has increased by 208.71% in one year.
Market Cap
3.41B
Enterprise Value
2.60B
Revenue
424.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.50
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.41B, an increase of 1,081.57%. That is a compound annual growth rate of 13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.39B | -2.14% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 3.82B |
| Genovate Biotechnology | 3.61B |
| Syngen Biotech | 3.54B |
| Shine-On BioMedical | 3.47B |
| 3D Global Biotech | 3.30B |
| SYN-TECH Chem. & Pharm. | 3.17B |
| Apex Biotechnology | 3.01B |
| GlycoNex Incorporation | 2.90B |